J Cancer Res Clin Oncol
December 2021
Purpose: This study aimed to assess whether the whole body metabolic active tumour volume (MTV), quantified on staging [F]FDG PET/CT, could further stratify stage IV non-small cell lung cancer (NSCLC) patients.
Methods: A group of 160 stage IV NSCLC patients, submitted to staging [F]FDG PET/CT between July 2010 and May 2020, were retrospectively evaluated. MTV was quantified.